Risk factors for radiation induced lymphopenia in patients with breast cancer receiving adjuvant radiotherapy
Kong, Feng-Ming Spring
JournalAnnals of Translational Medicine
PublisherAME Publishing Company
MetadataShow full item record
AbstractBackground: This study aimed to investigate radiation-induced lymphopenia and its potential risk factors in patients with breast cancer receiving adjuvant radiotherapy. Methods: Breast cancer patients received adjuvant radiotherapy (RT) at our hospital with peripheral lymphocyte counts (PLC) at pre-and immediately after RT (post-RT) were eligible. The primary endpoints were any grade of lymphopenia post-RT and nadir-PLC/pre-PLC <0.8. Patient characteristics, tumor factors, and treatment factors were collected for risk assessment. Data are presented as mean and 95% confidence interval (CI) unless otherwise specified. Matched analysis was used to compare the statistical significance between different RT techniques. Results: A total of 735 consecutive patients met the study criteria. The mean PLC was 1.58×109/L before and 0.99×109/L post-RT (P<0.001). At the end of RT, 60.5% of patients had lymphopenia. Univariate and multivariable logistic analyses showed that RT technique involving RapidArc, mean lung dose, and chemotherapy were significant risk factors (P<0.05) for lymphopenia. RT technique was the only significant risk factor (P<0.05) for nadir-PLC/pre-PLC <0.8. Patients treated with RapidArc had a significantly greater reduction of PLC along with greater V5 of the lungs, even after matching mean lung dose and radiated volume. Conclusions: Lymphopenia is common in patients with breast cancer after adjuvant RT. RT technique is the only significant factor for lymphopenia and nadir-PLC/pre-PLC <0.8, suggesting the significance of RT technique choice to minimize lymphopenia and improve treatment outcomes.
Rights/Terms2021 Annals of Translational Medicine. All rights reserved.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/16687
- Chemotherapy is a risk factor of lymphopenia before adjuvant radiotherapy in breast cancer.
- Authors: Chen F, Ma L, Wang Q, Zhou M, Nong Y, Jing H, Han Y, Liu Y, Hu Y, Yu H, Fu P, Kong FS
- Issue date: 2021 Aug 14
- Radiation-Induced Lymphopenia Predicts Poorer Prognosis in Patients With Breast Cancer: A Post Hoc Analysis of a Randomized Controlled Trial of Postmastectomy Hypofractionated Radiation Therapy.
- Authors: Sun GY, Wang SL, Song YW, Jin J, Wang WH, Liu YP, Ren H, Fang H, Tang Y, Zhao XR, Song YC, Yu ZH, Liu XF, Li YX
- Issue date: 2020 Sep 1
- Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy.
- Authors: Abravan A, Eide HA, Helland Å, Malinen E
- Issue date: 2020 May
- Association between treatment-related lymphopenia and survival in glioblastoma patients following postoperative chemoradiotherapy.
- Authors: Mapelli R, Julita C, Bianchi SP, Gallina N, Lucchini R, Midulla M, Puci F, Saddi J, Trivellato S, Panizza D, De Ponti E, Arcangeli S
- Issue date: 2021 Oct 6
- Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy.
- Authors: Chen D, Patel RR, Verma V, Ramapriyan R, Barsoumian HB, Cortez MA, Welsh JW
- Issue date: 2020 Sep